Oral Presentations (OP)

OP1 - P906
LONG-TERM SAFETY IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA (XLH) TREATED WITH BUROSUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY AGAINST FGF23: FINAL RESULTS OF A PHASE 3 TRIAL
M. L. Brandi, A. A. Portale, T. O. Carpenter, K. Briot, E. A. Imel, P. Kamenický, T. J. Weber, P. Pitukcheewanont, H. I. Cheong, S. Jan de Beur, Y. Imanishi, N. Ito, R. Lachmann, H. Tanaka, F. Perwad, L. Zhang, A. Skrinar, L. Rees, K. L. Insogna

OP2 - P1133
DOES ENDOGENOUS INFLAMMATION EXPLAIN ETHNIC VARIATION IN BONE MINERAL DENSITY? RESULTS FROM THE SABRE COHORT STUDY
R. Durdin, C. Parsons, E. M. Dennison, S. Williams, T. Tillin, N. Chaturvedi, C. Cooper, N. C. Harvey, K. Ward

OP3 - P581
AN INTERACTIVE BENEFITS AND BUDGET IMPACT CALCULATOR TO ESTIMATE POTENTIAL EFFECTS OF FRACTURE LIAISON SERVICES
R. Pinedo-Villanueva, A. Sami, S. Kolovos, E. Burn, M. Fujita, P. Halbout, C. Cooper, M. K. Javaid

OP4 - P236
PHASE I/III STUDY TO CONFIRM BIOEQUIVALENCE AND SAFE SWITCHING OF PROPOSED BIOSIMILAR DENOSUMAB IN POSTMENOPAUSAL OSTEOPOROSIS
J.-J. Body, C. Nie, B. Vogg, R. Eastell

OP5 - P255
SARCOPENIA AND HEALTH-RELATED OUTCOMES: AN UMBRELLA REVIEW OF OBSERVATIONAL STUDIES
N. Veronese, J. Demurtas, P. Soysal, L. Smith, O. Bruyere, J.-Y. Reginster, C. Beaudart, C. Cooper, M. Mirko, S. Maggi

OP6 - P463
HORMONE THERAPY REDUCES THE RISK OF FRACTURE REGARDLESS OF BASELINE FRACTURE RISK – RESULTS FROM THE WOMEN’S HEALTH INITIATIVE HORMONE THERAPY TRIALS
M. Lorentzon, H. Johansson, N. Harvey, E. Liu, C. Crandall, E. McCloskey, J. Kanis

OP7 - P559
DISABILITY-ADJUSTED LIFE YEARS RELATED TO FRAGILITY FRACTURES
F. Borgström, N. V. Norton, L. Karlsson, G. Ortsäter, N. C. Harvey, E. V. McCloskey, J. A. Kanis

OP8 - P1265
INTEGRATED SAFETY SUMMARY OF THE NOVEL, INTRA-ARTICULAR AGENT LORECIVIVINT (LOR; SM04690), A CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, IN SUBJECTS WITH KNEE OSTEOARTHRITIS
I. Simsek, C. Swearingen, S. Kennedy, J. Tambiah, C. Damatarca, Y. Yazici, N. Lane, M. Hochberg

OP9 - P590
INTRA-ARTICULAR CORTICOSTEROID KNEE INJECTION INDUCES A REDUCTION IN MENISCAL THICKNESS WITH NO TREATMENT EFFECT ON CARTILAGE VOLUME: A CASE-CONTROL STUDY
J.-P. Pelletier, J.-P. Raynauld, F. Abram, M. Dorais, P. Paiement, J. Martel-Pelletier

OP10 - P876
ASSOCIATION BETWEEN SARC-F AND QUALITY OF LIFE MEASURED WITH THE SARQOL® QUESTIONNAIRE IN OLDER, COMMUNITY-DWELLING SUBJECTS FROM THE SARCOPHAGE COHORT
A. Geerinck, C. Beaudart, M. Locquet, J.-Y. Reginster, O. Bruyère

OP11 - P438
FEASIBILITY, SAFETY AND EFFECTIVENESS OF A 16-WEEK HOME-BASED HOPPING AND JUMPING PILOT EXERCISE INTERVENTION IN POST-MENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
C.-A. Ng, L. B. McMillan, J. Mesinovic, L. Humbert, P. R. Ebeling, D. Scott

OP12 - P579
BONE DENSITOMETRY WORLDWIDE: A GLOBAL SURVEY BY THE ISCD AND IOF
M. A. Clynes, L.D. Westbury, E. M. Dennison, J. A. Kanis, M. K. Javaid, N. C. Harvey, M. Fujita, C. Cooper, W. D. Leslie, C. R. Shuhart

OP13 - P1104
EPIGENOME-WIDE ASSOCIATION STUDY IDENTIFIES ASSOCIATION BETWEEN 5’ WNT5B CPG DNA METHYLATION AND BONE MINERAL DENSITY AT THE FEMORAL NECK IN OLDER UK ADULTS
N. R. Fuggle, E. M. Dennison, C. G. Bell, C. Cooper

OP14 - P687
IDENTIFICATION OF FRAIL PATIENTS USING FEMORAL RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS)
G. Adami, G. Arioli, G. Bianchi, M. L. Brandi, C. Caffarelli, L. Cianferotti, G. Girasole, S. Gonnelli, M. Manfredini, M. Muratore, E. Quarta, L. Quarta, D. Gatti

OP15 - P954
FRACTURE RISK SCREENING USING FRAX IS EFFECTIVE FOR SECONDARY FRACTURE PREVENTION: A POST-HOC ANALYSIS OF THE SCOOP TRIAL
C. Parsons, E. M. Curtis, L. Shepstone, J. A. Kanis, E. Lenaghan, S. Clarke, R. Fordham, N. Gittoes, I. Harvey, R. The Netherlands, N. M. Redmond, A. Howe, T. Marshall, T. J. Peters, D. Torgerson, T. W. O’Neil, E. McCloskey, N. C. Harvey, C. Cooper

OP16 - P874
EVALUATING QUALITY OF LIFE IN FRAILTY: APPLICABILITY AND PSYCHOMETRIC PROPERTIES OF THE SARQOL® QUESTIONNAIRE
A. Geerinck, M. Locquet, O. Bruyère, J.-Y. Reginster, C. Beaudart

OP17 - P1019
HEALTH SERVICE USE AND RECOVERY OF QUALITY OF LIFE 12-MONTHS POST-FRACTURE: LATENT CLASS ANALYSES OF THE INTERNATIONAL COST AND UTILITIES RELATED TO OSTEOPOROTIC FRACTURES STUDY (ICUROS)
J. Talevski, K. Sanders, L. Busija, C. Connaughton, A. Beauchamp, G. Duque, K. Lim, F. Borgström, J. A. Kanis, S. Brennan-Olsen

OP18 - P1293
COMPARATIVE FUNCTIONAL STATUS BETWEEN CENTENARIES AND OLDER ADULTS WITH HIP FRACTURE IN SPAIN: DATA FORM THE SPANISH NATIONAL HIP FRACTURE REGISTRY (RNFC)
B. A. Cedeno-Veloz, M. Gonzalo Lazaro, C. Bermejo Boixareu, A. Guijarro Valtuena , L. Navarro Castellanos, P. Saez-Lopez, R. Queipo, C. Ojeda-Thies, P. Gomez Campelo, J. I. Gonzalez Montalvo

OP19 - P880
SARCOPENIA ACCORDING TO EWGSOP2 IS ASSOCIATED WITH GLOBAL SAGITTAL IMBALANCE OF THE SPINE IN OLDER ADULTS: THE SAFE COHORT STUDY
M. Hars, A. Faundez, J. Fechtenbaum, K. Briot, C. Roux, F. Herrmann, S. Ferrari, S. Genevay, S. Boudabbous, A. Trombetti

OP20 - P875
DEVELOPMENT OF A SHORT VERSION OF THE SARCOPENIA QUALITY OF LIFE (SARQOL®) QUESTIONNAIRE
A. Geerinck, O. Bruyère, M. Locquet, S. Gillain, C. Monseur, J.-Y. Reginster, C. Beaudart